Bearden, Carrie, Ph.D.

Research

Neurogenetic disorders; neurobehavioral biomarkers of serious mental illness

Appointments

• Professor, Departments of Psychiatry and Biobehavioral Sciences and Psychology, Semel Institute for Neuroscience and Human Behavior Brain Research Institute
• Integrative Center for Neurobehavioral Genetics
• Center for Autism Research and Treatment (CART)
• Director, Center for the Assessment and Prevention of Prodromal States (CAPPS)

Biography

Her research aims to understand genetic and neurobiological risk factors for the development of early-onset neuropsychiatric disorders. Dr. Bearden’s work examines these questions through two complementary lines of research:

1) The investigation of early biomarkers that predict disease risk and trajectory in at-risk populations; and

2) Translational approaches to understanding disrupted brain circuitry in highly penetrant genetic subtypes (e.g, 22q11.2 microdeletions)

Publications

1. Guest, RM, Aberizk, K, Addington, J, Bearden, CE, Cadenhead, KS, Cannon, TD et al.. Cultural variables influence performance on the MATRICS Consensus Cognitive Battery among people at clinical high risk for psychosis. Schizophr Res. 2025;280 :60-68. doi: 10.1016/j.schres.2025.04.019. PubMed PMID:40250131 .
2. Bearden, CE. Cannabis and Psychosis in Teens: Teens have access to extremely potent cannabis. Parents need to understand the risks. Sci Am. 2025;332 (5):90. doi: 10.1038/scientificamerican052025-6xqMsjiHh6k7H816RklzoC. PubMed PMID:40232981 .
3. Krystal, JH, Carter, CS, Bearden, CE, Barch, DM, Editors and Editorial Boards of Biological Psychiatry, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, and Biological Psychiatry: Global Open Science, Editorial Committee of the Biological Psychiatry family of journals et al.. Biological Psychiatry: Preserving the Promise. Biol Psychiatry. 2025; :. doi: 10.1016/j.biopsych.2025.03.023. PubMed PMID:40216051 .
4. Asgari-Targhi, A, Yao, B, Brown, L, Garcia, S, Nagendra, A, Chin, K et al.. Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia (Heidelb). 2025;11 (1):57. doi: 10.1038/s41537-025-00572-7. PubMed PMID:40195300 PubMed Central PMC11977264.
5. Billah, T, Cho, KIK, Borders, O, Chung, Y, Ennis, M, Jacobs, GR et al.. Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program. Schizophrenia (Heidelb). 2025;11 (1):55. doi: 10.1038/s41537-025-00560-x. PubMed PMID:40180978 PubMed Central PMC11968805.

Search PubMed